前列腺癌MRI新技术与研究进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要磁共振成像是诊断前列腺癌的有效方法。近些年来，磁共振波谱成像、扩散加权成像、体素内不相干运动扩散加权成像、扩散张量成像、扩散峰度成像、磁敏感加权成像等功能成像序列的问世和成熟，对前列腺癌的诊断、疗效评价等方面有很大帮助。本文就以上新技术在前列腺癌诊断等方面的研究进展予以综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	佟梓滨
	刘爱连

关键词 ：前列腺肿瘤, 磁共振成像

Abstract：MRI is an effective method in diagnosis of prostate cancer. In recent years, the function imaging techniques such as MRS, MR DWI, intravoxel incoherent motion diffusion weighted imaging(IVIM-DWI), MR diffusion tensor imaging(MR DTI), MR diffusion kurtosis imaging(MR DKI), MR SWI provides a great help in diagnosis of prostate cancer. This article is to review the progress of these new techniques in diagnosis of prostate cancer.

Key words： Prostatic neoplasms Magnetic resonance imaging

收稿日期: 2015-06-09

PACS:	Ｒ737.25
	Ｒ445.2

通讯作者: 刘爱连

引用本文:

佟梓滨，刘爱连. 前列腺癌MRI新技术与研究进展[J]. 中国临床医学影像杂志, 2016, 27(3): 207-211.
TONG Zi-bin, LIU Ai-lian. Progress and new techniques of MRI in diagnosis of prostate cancer. JOURNAL OF CHINA MEDICAL IMAGING, 2016, 27(3): 207-211.

链接本文:

http://www.jccmi.com.cn/CN/ 或 http://www.jccmi.com.cn/CN/Y2016/V27/I3/207

[1]Siegel R, Ma J, Zou ZH, et al. Cancer statistics[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
[2]韩苏军，张思维，陈万青，等. 中国前列腺癌发病现状和流行趋势分析[J]. 临床肿瘤学杂志，2013，18（4）：330-334.
[3]Nix JW, Turkbey B, Hoang A, et al. Very distal apical prostate tumors: identification on multiparametric MRI at 3 Tesla[J]. BJU Int, 2012, 110(11): 694-700.
[4]郭启勇. 实用放射学[M]. 3版. 北京：人民卫生出版社，2007：1025－1026.
[5]Rosenkrantz AB, Sabach A, Babb JS, et al. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor[J]. AJR, 2013, 201(3): 471-478.
[6]Ren J, Huan Y, Wang H, et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis[J]. Clin Radiol, 2008, 63(2): 153-159.
[7]张莹，苗华栋，张长萃. 前列腺癌3T MR表观扩散系数与动态增强半定量参数的相关性研究[J]. 临床放射学杂志，2013，32（2）：210-214.
[8]李春媚，陈敏，李飒英，等. 3.0T磁共振扩散张量成像诊断前列腺外周带癌的初步研究[J]. 临床放射学杂志，2012，31（3）：398-401.
[9]Schlemmer HP, Merkle J, Grobholz R, et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?[J]. Eur Radiol, 2004, 14(2): 309-317.
[10]Langer DL, vander Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI[J]. J Magn Reson Imaging, 2009, 30(2): 327-334.
[11]Chen YJ, Chu WC, Pu YS, et al. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer[J]. J Magn Reson Imaging, 2012, 36(4): 912-919.
[12]刘会佳，赵娓娓，任芳，等. 3.0T动态增强磁共振对前列腺癌的定量分析研究[J]. 放射学实践，2014，29（5）：477-481.
[13]Kurhanewiez J, Vjgneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24~0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805．
[14]Costello LC, Frankin RB, Narayan P. Citrate in the diagnosis of prostate cancer[J]. Prostate, 1999, 38(3): 237-245.
[15]Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy[J]. Urology, 1995, 45(3): 459-466.
[16]Scheenen TW, Fütterer J, Weiland E, et al. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study[J]. Invest Radiol, 2011, 46(1): 25-33.
[17]王霄英，周良平，丁建平，等. MRS对中国人前列腺癌鉴别诊断标准的初步研究[J]. 中国医学影像技术，2004，20（8）：1150-1153.
[18]Li B, Cai W, Lv D, et al． Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis[J]. J Magn Reson Imaging, 2013, 37(1): 194-200．
[19]Yamamura J, Salomon G, Buchert R, et al． MR imaging of prostate cancer: diffusion weighted imaging and (3D) hydrogen 1H-MR spectroscopy in comparison with histology[J]. Radiol Res Pract, 2011, 2011: 616852．
[20]周红俐，赵建农，郭大静，等. 扩散张量成像联合3D-1H-MRS对前列腺癌诊断效能的研究[J]. 第三军医大学学报，2014，36（1）：63-67.
[21]王希明，白人驹，赵新，等. 扩散加权成像鉴别前列腺癌及良性前列腺增生的价值[J]. 中华放射学杂志，2006，40（7）：690-694.
[22]Mazzoni LN, Lucarini S, Chiti S, et al. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values[J]. J Magn Reson Imaging, 2014, 39(3): 512-518.
[23]Jie C, Rongbo L, Ping T. The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis[J]. Eur Radiol, 2014, 24(8): 1929-1941.
[24]Lawrence EM, Gallagher FA, Barrett T, et al. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate or high-risk prostate cancer[J]. AJR, 2014, 203(3): 280-286.
[25]Rud E, Baco E, Lien D, et al. Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies[J]. AJR, 2014, 202(3): 241-246.
[26]Wetter A, Nensa F, Lipponer C, et al. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis[J]. Acta Radiol, 2015, 56(8): 1009-1015.
[27]Wang X, Qian Y, Liu B, et al. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3T[J]. Clin Radiol, 2014, 69(11): 1165-1170.
[28]Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications[J]. J Magn Reson Imaging, 2001, 13(4): 534-546.
[29]王微微，刘爱连. 扩散张量成像在腹部的应用[J]. 国际医学放射学杂志，2011，34（3）：257-260.
[30]Li C, Chen M, Li S, et al. Diffusion tension imaging of prostate at 3.0 Tesla[J]. Acta Radiol, 2011, 52(7): 813-817.
[31]Park SY, Kim CK, Park BK, et al. Diffusion-tensor MRI at 3T: differentiation of central gland prostate cancer from benign prostatic hyperplasia[J]. AJR, 2014, 202(3): 254-262.
[32]巩涛，袁淑绘，李莉莉，等. 前列腺癌DTI参数与Gleason评分的相关性研究[J]. 医学影像学杂志，2014，24（4）：574-577.
[33]王锡臻，沈蓁，王滨，等. 磁共振扩散张量成像在前列腺疾病诊断中的应用[J]. 临床放射学杂志，2010，29（7）：926-928.
[34]Gürses B, Kabakci N, Kovanlikaya A, et al. Diffusion tensor imaging of the normal prostate at 3 Tesla[J]. Eur Radiol, 2008, 18(4): 716-721.
[35]Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer[J]. Invest Radiol, 2007, 42(6): 412-419.
[36]Gürses B, Tasdelen N, Yencilek F, et al. Diagnostic utility of DTI in prostate cancer[J]. Eur J Radiol, 2011, 79(2): 172-176.
[37]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurogic disorders[J]. Radiology, 1986, 161(2): 401-407.
[38]Pang Y, Turkbey B, Bernardo M, et al. Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations[J]. Magn Reson Med, 2013, 69(2): 533-562.
[39]Mazaheri Y, Vargas HA, Akin O, et al. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting[J]. J Magn Reson Imaging, 2012, 35(3): 660-668.
[40]Dpfert J, Lemke A, Weidner A, et al. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging[J]. Magn Reson Imaging, 2011, 29(8): 1053-1058.
[41]Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging[J]. Magn Reson Med, 2005, 53(6): 1432-1440.
[42]Tamura C, Shinmoto H, Soga S, et al. Diffusion kurtosis imaging study of prostate cancer: preliminary findings[J]. J Magn Reson Imaging, 2014, 40(3): 723-729.
[43]Suo S, Chen X, Wu L, et al. Non-Gaussian water diffusion kurtosis imaging of prostate cancer[J]. Magn Reson Imaging, 2014, 32(5): 421-427.
[44]Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses[J]. J Magn Reson Imaging, 2006, 24(1): 41-51.
[45]Qi WX, Fu S, Zhang Q, et al. Efficacy and toxicity of anti-VEGF agents in patients with castration-resistant prostate cancer: a meta-analysis of prospective clinical studies[J]. Asian Pac J Cancer Prev, 2014, 15(19): 8177-8182.
[46]Yang ZS, Xu YF, Huang FF, et al. Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer[J]. Molecules, 2014, 19(5): 6851-6862.
[47]Gumus K, Koc G, Doganay S, et al. Susceptibility-based differentiation of intracranial calcification and hemorrhage in pediatric patients[J]. J Child Neurol, 2014, 30(8): 1029-1036.
[48]Bai Y, Wang MY, Han YH, et al. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification[J]. PLoS One, 2013, 8(1): e53237.